Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HDIVC in Critical COVID-19
NCT05029037Phase 3Unknown
- Start
- Sep 2021
- Primary completion
- Mar 2022
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of ascorbic acid in coronavirus disease 2019 (COVID-19). Status: unknown.
02
Drugs
ascorbic acid
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05029037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05029037.